Depression in cancer: new developments regarding diagnosis and treatment - PubMed (original) (raw)
Review
Depression in cancer: new developments regarding diagnosis and treatment
Charles L Raison et al. Biol Psychiatry. 2003.
Abstract
Considerable data demonstrate the high prevalence of symptoms of depression in patients with a wide variety of neoplastic disorders. Moreover, the dire consequences of these depressive symptoms in cancer patients have been well documented. Recent conceptual developments in the potential contributing mechanisms include increasing appreciation of the possibility that behavioral alterations in cancer patients may represent a "sickness syndrome" that results from activation of the inflammatory cytokine network. This sickness syndrome, which has been well documented in patients and laboratory animals exposed to inflammatory cytokines, includes symptoms that overlap with those seen in major depression. Conceptualizing these symptoms as components of cytokine-mediated sickness behavior has several important, and potentially novel, implications, including 1) an expansion of the neurobehavioral symptoms that are relevant to diagnosis and treatment; and 2) an increased appreciation of the potential diagnostic utility of peripheral markers of inflammation, as well as cytokine-related neurocircuitry alterations as defined by brain imaging. Treatment implications focus on the pathways by which inflammatory cytokines influence behavior, including therapeutic targets such as the inflammatory cytokines themselves, corticotropin-releasing hormone, and monoaminergic neurotransmitters and their precursors. Finally, recent data suggest that aggressive treatment strategies initiated before inflammation-inducing cancer treatments might prevent behavioral alterations, including depression, before they occur.
Similar articles
- Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms.
Myers JS. Myers JS. Oncol Nurs Forum. 2008 Sep;35(5):802-7. doi: 10.1188/08.ONF.802-807. Oncol Nurs Forum. 2008. PMID: 18765326 Review. - Role of Inflammation in Depression and Treatment Implications.
Felger JC. Felger JC. Handb Exp Pharmacol. 2019;250:255-286. doi: 10.1007/164_2018_166. Handb Exp Pharmacol. 2019. PMID: 30368652 - Pro- and anti-inflammatory cytokine associations with major depression in cancer patients.
Li M, Kouzmina E, McCusker M, Rodin D, Boutros PC, Paige CJ, Rodin G. Li M, et al. Psychooncology. 2017 Dec;26(12):2149-2156. doi: 10.1002/pon.4316. Epub 2016 Dec 6. Psychooncology. 2017. PMID: 27862626 - Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.
Felger JC, Lotrich FE. Felger JC, et al. Neuroscience. 2013 Aug 29;246:199-229. doi: 10.1016/j.neuroscience.2013.04.060. Epub 2013 May 3. Neuroscience. 2013. PMID: 23644052 Free PMC article. Review. - Inflammatory mechanisms in major depressive disorder.
Raedler TJ. Raedler TJ. Curr Opin Psychiatry. 2011 Nov;24(6):519-25. doi: 10.1097/YCO.0b013e32834b9db6. Curr Opin Psychiatry. 2011. PMID: 21897249 Review.
Cited by
- Annual Research Review: Neuroimmune network model of depression: a developmental perspective.
Nusslock R, Alloy LB, Brody GH, Miller GE. Nusslock R, et al. J Child Psychol Psychiatry. 2024 Apr;65(4):538-567. doi: 10.1111/jcpp.13961. Epub 2024 Mar 1. J Child Psychol Psychiatry. 2024. PMID: 38426610 Review. - Antidepressants for the treatment of depression in people with cancer.
Vita G, Compri B, Matcham F, Barbui C, Ostuzzi G. Vita G, et al. Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD011006. doi: 10.1002/14651858.CD011006.pub4. Cochrane Database Syst Rev. 2023. PMID: 36999619 Free PMC article. Review. - Prevalence and associated factors of depressive symptoms among patients with cancer receiving radiotherapy in southern Thailand: a university hospital-based cross-sectional study.
Pitanupong J, Phirom W, Kittichet R, Anantapong K. Pitanupong J, et al. BMC Palliat Care. 2023 Mar 16;22(1):25. doi: 10.1186/s12904-023-01145-0. BMC Palliat Care. 2023. PMID: 36922803 Free PMC article. - Incidence of psychiatric illness in patients with neuroendocrine tumors: a comparative population-based analysis.
Hallet J, Isenberg-Grzeda E, Law CHL, Barabash V, Zuckerman J, Singh S, Myrehaug SD, Assal A, Chan WC, Coburn NG, Mahar AL. Hallet J, et al. Support Care Cancer. 2022 Nov;30(11):9635-9646. doi: 10.1007/s00520-022-07365-z. Epub 2022 Oct 5. Support Care Cancer. 2022. PMID: 36197513 - Antidepressant medication use and prostate cancer recurrence in men with depressive disorders.
Haque R, Reading S, Irwin MR, Chen LH, Slezak J. Haque R, et al. Cancer Causes Control. 2022 Nov;33(11):1363-1372. doi: 10.1007/s10552-022-01623-5. Epub 2022 Sep 9. Cancer Causes Control. 2022. PMID: 36083407 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical